FDA Approves Linzess to Treat Constipation in Children, Teens
Linzess now approved for functional constipation in pediatric patients ages 6 to 17 years
FDA Advisers Meet to Decide Next COVID-19 Booster Shot
In a briefing paper, scientists say redesigned boosters should target at least one variant of the XBB strains
Crohn Disease More Common in People With Hidradenitis Suppurativa
Findings seen among pediatric patients aged 12 to 17 years
Adolescent Residential Addiction Facilities Largely Do Not Provide Buprenorphine
Few offer other evidence-based treatments
V114 Pneumococcal Vaccine Has Acceptable Safety Profile for Infants
Generally comparable proportion of infants with injection-site, systemic, vaccine-related, serious adverse events for V114 and PCV13
New Threshold Could Inform Rabies Postexposure Prophylaxis Decisions
Authors say a risk threshold of 0.0004 would be appropriate for postexposure prophylaxis administration
2018 to 2021 Saw Rise of Non-LSD Hallucinogen Use in U.S. Young Adults
Higher use seen among males, White people, and those from higher socioeconomic backgrounds
Chikungunya Vaccine Candidate Induces Strong Immune Response
VLA1553 induced seroprotective chikungunya virus neutralizing antibody levels in 98.9 percent of those receiving vaccine
Family-Based Intervention for Childhood Obesity Effective
Intervention can be implemented in primary care and improves weight outcomes for child, parents, and siblings
About 15 Percent of Children Received Mental Health Treatment in 2021
Children aged 12 to 17 years were more likely to have received any mental health treatment than those aged 5 to 11 years
